All Articles Tagged With: "ONJ"
Articles
Jaw Decay Fosamax Lawsuits Heading to Trial in State and Federal Court
In the coming months, trials will start in federal court and state court for lawsuits filed by individuals who allege they suffered jaw damage from Fosamax, with federal trials in New York City scheduled to begin in April and June, and a New Jersey state court trial scheduled to begin in July.
FDA Reviewing Link Between Fosamax and Fractures
The FDA indicated this week that it is still investigating a potential link between unexplained femur fractures and osteoporosis drugs, like Fosamax, Actonel, Boniva and Reclast, but questions whether such a causal connection exists.
Jaw Damage Lawsuit Against Fosamax Dismissed Weeks Before Trial
A federal judge has dismissed a lawsuit over Fosamax, saying that the plaintiff will be unable to establish at trial that the osteoporosis drug caused her to suffer debilitating jaw damage. The case had been scheduled for trial to begin on January 12, in what was to be the second of three bellwether trials [...]
Second Fosamax Lawsuit Trial Set to Begin January 12
A firm trial date of January 12 has been scheduled for a Fosamax lawsuit against Merck & Co. over their popular osteoporosis drug, which alleges that the drug caused a woman to suffer severe and debilitating deterioration of the jaw, known as osteonecrosis of the jaw (ONJ).
Fosamax Lawsuits for Jaw Problems with Under 3 Years of Use Will Proceed
A federal judge in New York has rejected a motion filed by Merck & Co. to dismiss 24 Fosamax lawsuits that claimed side effects of their osteoporosis drug caused severe and debilitating jaw problems after less than three years of use, finding that sufficiently reliable evidence exists that could allow a rational jury to find [...]
Jury Deliberations Continue in First Trial of Fosamax Litigation
Although jurors have indicated that they will not be able to reach an agreement in the first Fosamax trial over whether a 71 year old woman woman suffered debilitating jaw necrosis as a side effect of the osteoporosis drug, U.S. District Judge John Keenan has ordered them to continue deliberations in hopes of reaching a [...]
Fosamax Osteonecrosis Suit Submitted to Jury After Three Week Trial
A New York jury has begun deliberations over whether the osteoporosis drug Fosamax caused a 71 year old woman to suffer debilitating osteonecrosis of the jaw, in the first of nearly 1,000 similar Fosamax suits pending against Merck to go to trial.
Fosamax Trial Underway in New York
The first of three “bellwether” Fosamax trials has begun in the U.S. District Court for the Southern District of New York in Manhattan. The case, which involves allegations that the popular osteoporosis drug Fosamax caused a painful and disfiguring jaw injury, will likely be an indicator of how juries will respond to evidence in [...]
Fosamax Jaw Damage Trial Will Not Result in Punitive Damages
According to a pretrial order, Merck & Co. will not face the possibility of punitive damages in the first Fosamax trial scheduled to begin next month in New York. The case involves allegations that the drug maker failed to warn that their popular osteoporosis drug Fosamax increases the risk of debilitating jaw damage, known [...]
Fosamax Lawsuit Set to Begin August 11 in Federal MDL
The first in a series of Fosamax lawsuits are scheduled to begin next month in federal court over allegations that the popular osteoporosis drug causes permanent decay of the jawbone, known as osteonecrosis of the jaw.
